At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,133 enrolled
Drug / intervention
IORT with 20 Gyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
TARGeted Intraoperative radioTherapy With the INTRABEAM-System as an Advanced Boost in Patients With Breast Cancer - A Quality Control Registry in Germany (TARGIT BQR)
In Brief
An observational study evaluating IORT with 20 Gy for Breast Cancer. Completed, enrolled 1,133 participants across 1 site.
Detailed Summary
Quality Control Registry for IORT used as an anticipiated boost with 20 Gy at the applicator surface followed by EBRT
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2011
First PostedSep 2011
Primary CompletionDec 2020
TodayJul 2026
First PostedSep 23, 2011
Enrollment StartSep 1, 2011
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 9.3 yearsPosted 14.8 years ago
Interventions
IORT with 20 Gyradiation
Intraoperative radiotherapy with the INTRABEAM System with 20 Gy